Ultragenyx Pharmaceutical (RARE) Inventory Average (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) posted quarterly Inventory Average of $53.5 million for Q1 2026, up 17.54% year-over-year from $45.5 million in Q1 2025, and up 2.69% quarter-over-quarter from $52.1 million in Q4 2025.
Ultragenyx Pharmaceutical (RARE) Inventory Average (2018 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has reported Inventory Average for 9 consecutive years, with $53.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 17.54% year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $53.5 million (up 17.54% YoY), while the FY2025 annual figure was $48.5 million, up 22.83% from the prior year.
- Inventory Average grew to $53.5 million in Q1 2026 per RARE's latest filing, from $52.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $53.5 million in Q1 2026 and bottomed at $17.0 million in Q1 2022.
- Historically, Inventory Average has averaged $35.6 million across 5 years, with a median of $34.9 million in 2024.
- Annual changes were most pronounced in 2023 — Inventory Average surged 56.82% — and 2026, when it rose 17.54%.
- Ultragenyx Pharmaceutical's Inventory Average stood at $24.3 million in 2022, then surged by 35.29% to $32.9 million in 2023, then soared by 34.31% to $44.2 million in 2024, then rose by 17.96% to $52.1 million in 2025, then increased by 2.69% to $53.5 million in 2026.
- Business Quant data shows RARE's Inventory Average at $53.5 million in Q1 2026, $52.1 million in Q4 2025, and $49.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.61 Bn | 2.33 Bn | 180.00 Mn | 57.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.00 Mn |
| Mar 31, 2026 | 53.50 Mn |
| Dec 31, 2025 | 52.10 Mn |
| Sep 30, 2025 | 49.35 Mn |
| Jun 30, 2025 | 46.26 Mn |
| Mar 31, 2025 | 45.52 Mn |
| Dec 31, 2024 | 44.17 Mn |
| Sep 30, 2024 | 41.74 Mn |
| Jun 30, 2024 | 38.02 Mn |
| Mar 31, 2024 | 34.94 Mn |
| Dec 31, 2023 | 32.89 Mn |
| Sep 30, 2023 | 30.03 Mn |
| Jun 30, 2023 | 27.44 Mn |
| Mar 31, 2023 | 26.69 Mn |
| Dec 31, 2022 | 24.31 Mn |
| Sep 30, 2022 | 21.46 Mn |
| Jun 30, 2022 | 19.44 Mn |
| Mar 31, 2022 | 17.02 Mn |
| Dec 31, 2021 | 15.71 Mn |
| Sep 30, 2021 | 15.14 Mn |